Context Therapeutics (NASDAQ: CNTX)

Last close As at 18/03/2024

1.22

0.00 (0.00%)

Market capitalisation

USD19m

Latest Insights

View More
Doctor with cancer patient

Balance Sheet

Forecast net debt (US$m)

N/A

Forecast gearing ratio (%)

N/A

Share Price Performance

Price Performance
% 1M 3M 12M
Actual 119.1 79.4 (38.7)
Relative 106.7 60.8 (47.6)
52 week high/low US$2.3/US$0.5

Financials

Edison Investment Research is terminating coverage on Context Therapeutics (CNTX). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Y/E Dec Revenue (US$m) EBITDA (US$m) PBT (US$m) EPS (fd) (c) P/E (x) P/CF (x)
2021A 0.0 (10.5) (10.6) (373.72) N/A N/A
2022A 0.0 (15.4) (14.8) (93.00) N/A N/A
2023E N/A N/A N/A N/A N/A N/A
2024E N/A N/A N/A N/A N/A N/A

Further insights

insight

Healthcare

Healthcare Week 2023

insight

Healthcare

Forging better lives: Seeking radical change for cancers

Analyst of the week

Andy Murphy

Andy Murphy

Director, Financials & Industrials

Read latest

Thematics

thematic

Investment Companies

Listed private equity – Performing a balancing act

thematic

Consumer

ConsumerWatch – At least someone loves me

thematic

TMT

MediaWatch – Rinse and repeat

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free